Vashishtha Vipin M, Kumar Puneet
Department of Pediatrics, Mangla Hospital & Research Center, Shakti Chowk, Bijnor, Uttar Pradesh, 246701, India.
Kumar Child Clinic, KM Chowk, Sector 12, Dwarka, New Delhi, India.
Indian Pediatr. 2025 Jul 22. doi: 10.1007/s13312-025-00119-0.
India is experiencing frequent outbreaks of seasonal influenza viruses, similar to the ongoing influenza type B in many states. Influenza viruses are linked to significant morbidity and mortality, particularly among children under 5 years of age. Despite the considerable burden of influenza and widespread surveillance throughout India, data on the true national burden is, at best, inconsistent. The year-round presence of influenza activity and two distinct peaks present significant challenges to India's single-dose annual influenza vaccination. This situation is further complicated by frequent vaccine updates due to ongoing 'antigenic drifts' in circulating influenza viruses and the short durability of most flu vaccines. This perspective briefly explores the strategies that can be implemented to maximize the benefits of the available vaccines.
印度正频繁爆发季节性流感病毒,这与许多邦正在流行的乙型流感类似。流感病毒与较高的发病率和死亡率相关,尤其是在5岁以下儿童中。尽管流感负担沉重且印度各地都有广泛监测,但关于全国实际负担的数据充其量也是不一致的。流感活动全年存在且有两个明显高峰,这给印度的单剂量年度流感疫苗接种带来了重大挑战。由于流行的流感病毒不断出现“抗原漂移”以及大多数流感疫苗的有效期较短,疫苗频繁更新使这种情况更加复杂。本文简要探讨了为最大限度地发挥现有疫苗的效益可实施的策略。